The Argentine healthcare system is currently under severe strain due to the emergence of fentanyl contaminated with bacteria, resulting in 69 confirmed infections and at least 33 deaths in hospital patients who were given the drug for pain relief. Federal authorities have identified multiple batches of the contaminated opioid, leading to an urgent suspension of its use throughout the country. Technical analyses have pinpointed specific harmful bacteria in both the affected patients and the fentanyl produced by certain laboratories, highlighting the grave public health implications and prompting judicial actions against the involved entities.
The clinical use of fentanyl contaminated with bacteria is wreaking havoc on the Argentine healthcare system, with authorities confirming 69 infections and 33 related deaths.
The federal courts and the National Drug Administration (ANMAT) have warned of at least three batches of contaminated fentanyl, necessitating urgent measures to locate and suspend its use.
Technical analysis revealed the presence of Klebsiella pneumoniae and Ralstonia pickettii bacteria in both infected individuals and in the injectable fentanyl produced by HLB Pharma Group and Laboratorio Ramallo.
Health authorities are concerned that the number of infected individuals may exceed the confirmed cases, as most fatalities have occurred in men aged between 45 and 64.
Collection
[
|
...
]